TransVaginal Female Sexual and SUI Treatment

The first of three already conducted clinical pilots, relate to using MoreNova for female Sexual Improvement and Stress Urinary Incontinence. The pilots presented at the International Continence Society (ICS) 2021 Melbourne conference. Treatment was offered to women suffering from stress urinary incontinence, sexual dysfunction or both conditions.  Initial results are highly encouraging.  Low intensity shockwaves promote angiogenesis, increase nitric oxide release (NO), induces release of vascular endothelial growth factor (VEGF), stimulates reproduction of stem cells and effects tissue regeneration. Patented MoreNova applies low intensity shockwaves using patented applicators configured to deliver energy to anatomy of various shapes, i.e., linear, area and tubular.  The first ones allow external treatments while the latter allows internal vaginal treatments. Since low intensity shockwaves are painless and do not produce heat, concerns related to heat-related risk associated with other technologies are avoided.  Internal and external vaginal treatment allows for the ability to treat both improved sexual function as well as urinary incontinence and pain-related conditions.